A diagnosis with cancer, especially stage IV disease, is one of the most stressful and most significant moments in life. It takes a tremendous toll on patients and their families. Patients are forced to make overwhelming decisions, often with limited information and little time to decide. Current standard-of-care treatments can be difficult, prolonged, and expensive. The National Cancer Institute states that the annual estimated total cost of cancer care in the United States alone is approximately $200 billion.

​

Since the first chemotherapy treatments were discovered approximately 80 years ago, the tireless work of medical and research teams has changed the lives of countless patients, many of whom remain in long-term remission with probable cures. However, for most types of cancer, especially stage IV disease, standard-of-care treatments have not provided high rates of cures. At General Oncology, it is our conviction that a cure for most cancers is now within reach. That conviction drives us every day.

Our focus is on creating unique drug combinations to achieve what has long been an elusive goal: satisfying the logical scientific requirements for curing cancer without incurring significant lasting toxicity to patients.